Remote Smoking Cessation Research Study

Researchers at the Medical University of South Carolina are conducting a study to determine the effectiveness of different smoking cessation treatments.

Fast Facts

Daily Cigarette Smoker Looking to Quit

Ages 21+

Compensation Provided

Remote

Study Background

The ADAPT study is investigating the effectiveness of different treatments for people struggling with smoking cessation.

The study aims to understand whether switching to an alternative treatment is more effective than continuing with the same treatment for individuals struggling to quit smoking. Participants will be provided with either nicotine patches and lozenges or varenicline (Chantix) for an initial 4-week period, and those who are not successful in quitting may be randomly assigned to continue with the same medication or switch to the other. Additionally, if needed, participants may be offered an e-cigarette as a treatment option in the later stages of the study. The study’s goal is to explore how different treatments can help people overcome challenges to quitting smoking.

Join our study to help determine if switching treatments could be the key to successfully quitting smoking!

Study Background

The ADAPT study is investigating the effectiveness of different treatments for people struggling with smoking cessation.

The study aims to understand whether switching to an alternative treatment is more effective than continuing with the same treatment for individuals struggling to quit smoking. Participants will be provided with either nicotine patches and lozenges or varenicline (Chantix) for an initial 4-week period, and those who are not successful in quitting may be randomly assigned to continue with the same medication or switch to the other. Additionally, if needed, participants may be offered an e-cigarette as a treatment option in the later stages of the study. The study’s goal is to explore how different treatments can help people overcome challenges to quitting smoking.

Join our study to help determine if switching treatments could be the key to successfully quitting smoking!

Additional Information

The purpose of the study is to determine if switching to a different treatment is better than continuation of the same treatment, for those who struggle to quit smoking. It is hoped that what is learned from the study will benefit individuals who want to quit smoking in future.

You may qualify for a study if you meet the following criteria:

Inclusion Criteria:

  • 21 years and older
  • Smoke cigarettes daily
  • Not currently using smoking cessation medications or e-cigarettes

Exclusion Criteria:

  • Cannot be currently pregnant, breastfeeding, or planning to become pregnant
  • Cannot have medical contraindications for varenicline or NRT
  • Not taking medications such as Wellbutrin, Bupropion, Zyban, or Varenicline

All participants will have 3 treatment phone calls, at Weeks 0, 4, and 8. These phone calls will be used to discuss the product or treatment you will be using, and general strategies to quit. They should last about 15-20 minutes.

If you agree to participate in the study, you will receive either nicotine patches and lozenges or varenicline (Chantix) for 4 weeks to help you quit smoking. If your treatment is successful, you will continue with the same medication for another 4 weeks. If it’s not effective, you will be randomly assigned to either continue the same treatment or switch to the other option. After 8 weeks, we will reassess your progress, and if necessary, you will either continue with your treatment or switch to an e-cigarette. The goal of the study is to determine if switching treatments is more effective for those struggling to quit. All study assessments will be done remotely, and the treatments will be provided free of charge for 12 weeks.

As a participant, you can receive up to $200.

There is no cost for you to participate in our research study.